Advisor Group’s Aratana Therapeutics, Inc. PETX Stock Holding History

Advisor Group’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,600	Closed	-$8K	–	5590
2019 Q2	$8K	Hold	1,600	–	–	﹤0.01%	4515
2019 Q1	$6K	Buy	1,600 +800	+100%	+$3.47K	﹤0.01%	4638
2018 Q4	$5K	Buy	+800	New	+$4.88K	﹤0.01%	4566
2017 Q3	–	Sell	-1,398	Closed	-$10K	–	5037
2017 Q2	$10K	Buy	1,398 +845	+153%	+$5.2K	﹤0.01%	3950
2017 Q1	$3K	Buy	+553	New	+$3.73K	﹤0.01%	4332

Other funds holding PETX

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Advisor Group's PETX Position: Q3 2019 in Review

Advisor Group sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 1,600 shares — an estimated $8K sold.

Advisor Group first reported a position in PETX in Q1 2017 and held it in 5 quarters. The position peaked at $10K in Q2 2017. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.

Advisor Group reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
Advisor Group sold 1,600 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $8K.
Advisor Group first reported a position in Aratana Therapeutics, Inc. in Q1 2017 and held it in 5 quarters.
Advisor Group's Aratana Therapeutics, Inc. position peaked at $10K in Q2 2017.
2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.

Based on Advisor Group's 13F filing for Q3 2019, filed 13 Nov 2019.